5Yoshizawa S,Yasuoka A.Kikuchi Y,et al. A 5-day cosurse of oral desensitization to trimethoprim/sulfamethoxazole (T/S) in patients with human immunodeficiency virus type1 infection who were previously intolerant to T/S [J]. Ann Allergy Asthma Immunol, 2000
6Petty BG, Black JR, Hendrix CW. et al. Escalating multiplc-dose safcty and tolerance study of oral WR6062 in HIV-infected subjects:AIDS clinical trials group 173[J]. J Acquir Immune Defic Syndr, 1999,21(1 ): 26-32.
7Delclaux C,Zahar JR,Amraoui G,et al. Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in non-human immunodeficiency virus-infected patients: retrospective study of 31 patients [J ]. Clin Infection Dis, 1999,29(3) :670-672.
8Horis S,Carvalho TL,DEmengeot J. CD25 + regulatory T cells suppress CD4+ T cell-mediated pulmonaryhyperinflammation driven by Pneumocystis carinii in immunodeficient mice [J]. Eur J Immunol, 2002,32 (5):1282-1291.
9Smulian AG,Sullivan DW,Theus SA. Immunization with recombinant Pneumocystis carinii P55 antigen provides partial protein against infection: characterization of epitope recognition associated with immunization [J]. Microbe Infeetion,2000,2:127-136.
10Madhi SA, Catland C, Ismail K, et al. Ineffectiveness trimethoprim-sulfamethoxazole prophylaxis and importance of bacterial and viral coinfections in African children with PCP[J]. Clin Infect Dis ,2002,35(9):1120-1126.
